Αρχική World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma Από Ogkologos - 30 Οκτωβρίου, 2024 3658 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Study presents an AI-guided approach to target cancer antigens 1 Οκτωβρίου, 2025 Efficacy and Safety of Patritumab Deruxtecan in EGFR-mutated NSCLC Resistant to... 16 Ιουνίου, 2021 FDA Approves Lurbinectedin in Combination with Atezolizumab or Atezolizumab and Hyaluronidase-tqjs... 16 Οκτωβρίου, 2025 Alex Trebek Admits Undergoing Chemo For Stage 4 Pancreatic Cancer Has... 15 Μαΐου, 2019 Φόρτωση περισσοτέρων HOT NEWS Nivolumab plus Ipilimumab Improves PFS Over Chemotherapy Among Previously Untreated Patients... Boy Born With Heart Defect Gets Surgery To Help It Triple... FDA Approves Atezolizumab for BRAF V600 Mutation Positive Unresectable or Metastatic... What is Mindfulness?